...
首页> 外文期刊>Journal of laparoendoscopic and advanced surgical techniques, Part A >Laparoscopic central pancreatectomy with pancreaticojejunostomy: Preliminary experience with 8 cases
【24h】

Laparoscopic central pancreatectomy with pancreaticojejunostomy: Preliminary experience with 8 cases

机译:腹腔镜中央胰腺切除术联合胰空肠造口术8例初步体会

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Central pancreatectomy has been accepted as an alternative procedure for treating benign or low-grade malignant tumors in the pancreatic neck or proximal body of the pancreas, which preserves pancreatic parenchyma and function. In this study, we present our experience of laparoscopic central pancreatectomy with pancreaticojejunostomy. Patients and Methods: From April 2011 to February 2013, 8 patients underwent laparoscopic central pancreatectomy with a Roux-en-Y modified "dunking" or duct-to-mucosa pancreaticojejunostomy for benign or low-grade malignant tumors in the pancreatic neck or proximal body of the pancreas at the Department of General Surgery, Sir Run Run Shaw Hospital, Hangzhou, China. Surgical procedure, postoperative course, and follow-up data were collected. Results: Laparoscopic central pancreatectomy was performed successfully in all the patients. The pancreaticojejunostomy was executed with a modified "dunking" pancreaticojejunostomy (n=7) or duct-to-mucosa pancreaticojejunostomy (n=1). The mean operative time was 286±27 minutes (range, 250-330 minutes), with a mean blood loss of 57±21 mL (range, 30-100 mL). Mortality was 0%, and perioperative morbidity was 37.5% (pancreatic fistula [grade A], bleeding of a splenic vein branch, and retroperitoneal infection). The median postoperative hospital stay was 10 days (range, 6-38 days). At a median follow-up of 7.5 months (range, 2-24 months), all patients were alive without any exocrine or endocrine insufficiency or recurrence. Conclusions: Laparoscopic central pancreatectomy is feasible and safe. The modified "dunking" pancreaticojejunostomy can be performed safely in this approach.
机译:背景:中央胰腺切除术已被视为治疗胰腺颈部或胰腺近端体的良性或低度恶性肿瘤的替代方法,可保留胰腺实质和功能。在这项研究中,我们介绍了腹腔镜中央胰腺切除术与胰空肠吻合术的经验。患者与方法:2011年4月至2013年2月,有8例患者接受了经Roux-en-Y改良的“灌洗”或导管-粘膜胰空肠吻合术进行腹腔镜中央胰腺切除术,以治疗胰腺颈部或近端的良性或低度恶性肿瘤中国杭州市润逸逸夫医院普外科胰腺。收集手术过程,术后病程和随访数据。结果:所有患者均成功进行了腹腔镜中央胰腺切除术。胰空肠吻合术采用改良的“灌篮式”胰空肠吻合术(n = 7)或导管至粘膜胰空肠吻合术(n = 1)进行。平均手术时间为286±27分钟(范围250-330分钟),平均失血为57±21 mL(范围30-100 mL)。死亡率为0%,围手术期发病率为37.5%(胰瘘[A级],脾静脉分支出血和腹膜后感染)。术后中位住院时间为10天(范围6-38天)。中位随访7.5个月(2-24个月),所有患者均活着,没有任何外分泌或内分泌功能不全或复发。结论:腹腔镜中央胰腺切除术是可行且安全的。改良的“灌洗”胰空肠吻合术可以用这种方法安全地进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号